Trillium Group
8
4M
7
0.33
4
0.12
3
- Stages of investment
- Areas of investment
Summary
Trillium Group is the famous VC, which was founded in 1997. The main office of represented VC is situated in the Pittsford. The venture was found in North America in United States.
Among the most successful fund investment fields, there are Biopharma, Medical Device. The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline iCardiac Technologies, OyaGen, Omni-ID Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The fund is constantly included in less than 2 deals per year. Deals in the range of 5 - 10 millions dollars are the general things for fund. The real fund results show that this VC is 42 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2017. The top activity for fund was in 2003. Comparing to the other companies, this Trillium Group performs on 9 percentage points more the average number of lead investments.
The overall number of key employees were 1.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Trillium Group, startups are often financed by Stonehenge Capital, Cody Gate Ventures, Advantage Capital. The meaningful sponsors for the fund in investment in the same round are YFY Inc., Stonehenge Growth Equity, Stonehenge Growth Capital. In the next rounds fund is usually obtained by YFY Inc., Stonehenge Growth Equity, Norwest Venture Partners.
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 4
- Exits
- 3
- Rounds per year
- 0.33
- Follow on index
- 0.12
- Investments by industry
- Biotechnology (3)
- Health Care (2)
- Logistics (2)
- RFID (2)
- Hardware (2) Show 13 more
- Investments by region
-
- United States (8)
- Peak activity year
- 2003
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 2M
- Group Appearance index
- 0.38
- Avg. company exit year
- 10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| VirtualScopics | 10 Feb 2003 | Biotechnology, Medical Device, Pharmaceutical | Late Stage Venture | 3M | United States, New York, Rochester |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.